by The RxPx Team | Aug 19, 2026 | Articles
FOR IMMEDIATE RELEASE RxPx Accelerates Growth with Leadership Expansion as AI-Powered Patient Safety and Support Platform Demonstrates Significant Gains in Adherence and Speed to Therapy Leadership expansion, strategic pharmaceutical partnerships and platform...
by The RxPx Team | Jul 17, 2026 | Articles
Every pharmaceutical launch is measured against ambitious commercial forecasts. Brand teams spend years preparing for approval, market access, and physician uptake. Pharma invests upwards of $1-2 billion and 10+ years to bring a therapy to market. Yet once approved,...
by The RxPx Team | Jul 7, 2026 | Articles
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust? That was the central question explored during Medicines Australia’s recent webinar, Conversations & The Code: Compliance and Decision Making – Navigating AI and Emerging...
by The RxPx Team | May 26, 2026 | Articles
At Asembia AXS26, one message surfaced repeatedly across conversations with manufacturers, specialty pharmacies, hubs, and patient support leaders: healthcare fragmentation is becoming impossible to ignore. Disconnected systems, siloed vendors, fragmented patient...
by The RxPx Team | Nov 26, 2025 | Articles
“Every extra week of delay in treatment can reduce survival rates by up to 8%.” Speed saves lives – yet, across therapeutic areas, delays between diagnosis, prescription, and treatment remain a critical weak point in patient care. Many pharma leaders recognize...
by The RxPx Team | Nov 4, 2025 | Articles
At NEXT Pharma Australia 2025, healthcare and life sciences leaders gathered to answer one defining question: How do we integrate artificial intelligence into pharma in a way that’s safe and ethical? This year’s event marked a historic milestone – the first time...
